Talphera (TLPH) Amortizatization of Intangibles (2011 - 2023)
Talphera (TLPH) posted quarterly Amortizatization of Intangibles of $100000.0 for Q3 2023, little changed year-over-year from $100000.0 in Q3 2022, and little changed quarter-over-quarter from $100000.0 in Q2 2023.
Talphera (TLPH) Amortizatization of Intangibles (2011 - 2023) Analysis & Trends
Talphera's Amortizatization of Intangibles history runs 13 years deep, the most recent figure standing at $100000.0 for Q3 2023.
- In Q3 2023, Amortizatization of Intangibles changed 0.0% year-over-year to $100000.0; the TTM figure through Jun 2024 stood at $100000.0 (down 66.44% YoY), while the FY2023 annual figure was $53000.0, down 86.51% from the prior year.
- Amortizatization of Intangibles for Q3 2023 stood at $100000.0, roughly flat from $100000.0 in the prior quarter.
- The five-year high for Amortizatization of Intangibles was $700000.0 in Q2 2022, with the low at $38000.0 in Q1 2023.
- The 5-year median for Amortizatization of Intangibles is $154000.0 (2021), against an average of $187631.6.
- The sharpest annual moves came in 2022 and 2023: Amortizatization of Intangibles soared 250.0% in 2022, then plunged 85.71% in 2023.
- Talphera's Amortizatization of Intangibles stood at $241000.0 in 2019, then gained by 2.07% to $246000.0 in 2020, then plunged by 37.4% to $154000.0 in 2021, then tumbled by 61.04% to $60000.0 in 2022, then soared by 66.67% to $100000.0 in 2023.
- Business Quant data shows TLPH's Amortizatization of Intangibles at $100000.0 in Q3 2023, $100000.0 in Q2 2023, and $38000.0 in Q1 2023.
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Amortizatization of Intangibles (Qtr) |
|---|---|---|---|---|---|
| 1 | Haleon | 43.91 Bn | 42.95 Bn | - | - |
| 2 | Teva Pharmaceutical Industries | 43.15 Bn | 39.49 Bn | 2.15 Bn | - |
| 3 | Zoetis | 31.52 Bn | 29.84 Bn | 1.05 Bn | - |
| 4 | Takeda Pharmaceutical | 28.58 Bn | 22.78 Bn | 5.10 Bn | - |
| 5 | United Therapeutics | 22.16 Bn | 19.50 Bn | 683.80 Mn | - |
| 6 | Viatris | 18.76 Bn | 17.87 Bn | 1.46 Bn | - |
| 7 | Neurocrine Biosciences | 15.48 Bn | 15.09 Bn | 935.80 Mn | 900,000.00 |
| 8 | Elanco Animal Health | 11.69 Bn | 11.16 Bn | 798.00 Mn | - |
| 9 | Dr Reddys Laboratories | 10.13 Bn | 9.96 Bn | - | - |
| 10 | Talphera | 90.63 Mn | 90.63 Mn | - | - |
Historic Data
Download Data| Date | Value |
|---|---|
| Sep 30, 2023 | 100,000.00 |
| Sep 30, 2023 | 100,000.00 |
| Jun 30, 2023 | 100,000.00 |
| Jun 30, 2023 | 100,000.00 |
| Mar 31, 2023 | 38,000.00 |
| Mar 31, 2023 | 38,000.00 |
| Dec 31, 2022 | 60,000.00 |
| Dec 31, 2022 | 60,000.00 |
| Sep 30, 2022 | 100,000.00 |
| Sep 30, 2022 | 100,000.00 |
| Jun 30, 2022 | 700,000.00 |
| Jun 30, 2022 | 700,000.00 |
| Mar 31, 2022 | 134,000.00 |
| Mar 31, 2022 | 134,000.00 |
| Dec 31, 2021 | 154,000.00 |
| Dec 31, 2021 | 154,000.00 |
| Sep 30, 2021 | 100,000.00 |
| Sep 30, 2021 | 100,000.00 |
| Jun 30, 2021 | 200,000.00 |
| Jun 30, 2021 | 200,000.00 |